Summary
The transplantable line-10 hepatocellular carcinoma of guinea-pigs has been used as a model for the study of immunotherapy of malignant tumors. Cure rates of up to 100% have been obtained with ReGl-CM from 0 antigen-deficient (Re) mutant strains of Enterobacteriaceae, provided they were combined with mycobacterial trehalose dimycolate (cord factor, P3). Whereas highly endotoxic LPS extracts from all wild-type strains so far tested have failed to cause tumor regression, acid hydrolysis of such LPS samples led to residual fractions (RESI) that cross-reacted serologically with ReGl-CM samples (Chang and Nowotny, 1975) and provided cure rates up to 100%. RESI from Serratia marcescens was essentially nonpyrogenic and 100 times less lethal for chick embryos than potent endotoxins. Antigenic material associated with endotoxic extracts appears to be cryptic or sterically hindered from being effective in wild-type LPS but is exposed in ReGl and RESI samples.
Reduction of the aminoacid content of ReGl-CM by microparticulate silica gel chromatography or by treatment with Triton X-100 significantly lowered the ability to bring about tumor regression without affecting endotoxicity. Antitumor activity could be restored by the addition of synthetic N-acetyl-muramyl-l-seryl-d-isoglutamine (MDP) or a nontoxic lipoid side fraction recovered during the isolation of ReGl-CM, which contained a small amount of peptidic substances. It is concluded that the addition of peptidic material, which may act as an adjuvant, to endotoxins is required to make them useful for immunotherapy of the weakly immunogenic line-10 tumor.
Chemical procedures known to ‘detoxify’ endotoxins while retaining adjuvanticity, such as succinylation and phthalylation, resulted in complete loss of endotoxicity and tumor-regressive potency of ReGl-CM. Transesterification with sodium methoxide led to a water-soluble phase, which cured 50% of tumor-bearing animals even though lethality and pyrogenicity were reduced by 100 times and 50 times, respectively. Thus there was no direct correlation between endotoxic potency and tumor-regressive activity. In addition, our findings indicate that a low level of toxicity may be required to obtain optimal levels of tumoricidal action.
Similar content being viewed by others
Abbreviations
- P3:
-
trehalose dimycolate isolated by microparticulate silica gel chromatography (Ribi et al., 1974)
- LPS:
-
lipopolysaccharide from wild-type gram-negative bacteria
- ReGl:
-
endotoxic glycolipids from Re mutant gram-negative bacteria
- CM:
-
chloroformmethanol
- PW:
-
phenol-water
- PCP:
-
phenol-chloroform-petroleum ether
- ReGl-CM:
-
ReGl-PW, ReGl-PCP refer to ReGl extracted with CM, PW, or PCP, respectively
- ACP:
-
acetone-precipitated by-product of ReGl-CM
- B1, B2, B4:
-
chromatographic fractions of ReGl-CM
- lipid A:
-
hydrochloric acid hydrolyzate of LPS or ReGl
- RESI:
-
organic solvent-insoluble fraction of lipid A (Chang and Nowotny, 1975)
- KDO:
-
keto-3-deoxyoctonate
- BSA:
-
bovine serum albumin
- CWS:
-
cell wall skeleton of BCG (Bacillus Calmette-Guérin)
- PPD:
-
purified protein derivative (tuberculoprotein)
- TAP:
-
tuberculin-active peptide
- MDP:
-
N-acetyl-muramyl-l-seryl-d-isoglutamine
References
Adam, A., Ciorbaru, R., Ellouz, F., Petit, J.-F., Lederer, E.: Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem. Biophys. Res. Commun. 56, 561 (1974)
Adam, A., Devys, M., Souvannavong, V., Lefrancier, P., Choay, J., Lederer, E.: Correlation of structure and adjuvant activity of N-acetyl-muramyl-l-alanyl-d-isolgutamine (MDP), its derivatives and analogues. Antiadjuvant and competition properties of stereoisomers. Biochem. Biophys. Res. Commun. 72, 339 (1976)
Alexander, P.: Back to the drawing board — the need for more realistic model systems for immunotherapy. Cancer 40, 467 (1977)
Alexander, P., Evans, R.: Endotoxin and double-stranded RNA render macrophages cytotoxic. Nature [New Biol.] 232, 76 (1971)
Arendt, A., Kolodziejczk, A., Sokolowska, T.: Synthesis of mucopeptide fragments of bacteria cell walls containing diaminopimelic acid. Part VII. Protected muramyl-l-alanine — an essential intermediate for muropeptide synthesis. Rocz. Chem. 48, 1707 (1974)
Azuma, I., Ribi, E. E., Meyer, T. J., Zbar, B.: Biologically active components from mycobacterial cell wall. I. Isolation and composition of cell wall skeleton and component P3. J. Natl. Cancer Inst. 52, 95 (1974)
Azuma, I., Yamawaki, M., Yasumoto, K., Yamamura, Y.: Antitumor activity of Nocardia cell wall skeleton preparations in transplantable tumors in syngeneic mice and patients with malignant pleurisy. Cancer Immunol. Immunother. 4, 95 (1978)
Belleau, B., Malek, G.: A new convenient reagent for peptide synthesis. J. Am. Chem. Soc. 90, 1651 (1968)
Berendt, M. J., North, R. J., Kirsten, D. P.: The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity. J. Exp. Med. 148, 1550 (1978)
Brailovsky, C., Trudel, M., Lallier, R., Nigam, V. N.: Growth of normal and transformed rat embryo fibroblasts. Effects of glycolipids from Salmonella minnesota R mutants. J. Cell Biol. 57, 124 (1973)
Cantrell, J. L., Ribi, E., McLaughlin, C.: Passive transfer with spleen cells from guinea pigs cured of hepatocarcinoma by nonspecific immunotherapy. Cancer Immunol. Immunother. 4, 21 (1978)
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., Williamson, B.: An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666 (1975)
Chang, C.-M., Nowotny, A.: Relation of structure to function in bacterial 0-antigens. VII. Endotoxicity of lipid A. Immunochemistry 12, 19 (1975)
Chapman, H. A., Jr., Hibbs, J. B., Jr.: Modulation of macrophage tumoricidal capability by components of normal serum: A central role for lipid. Science 197, 282 (1977)
Chedid, L., Audibert, F., Bona, C., Damais, C., Parant, F., Parant, M.: Biologic activities of endotoxins detoxified by alkylation. Infect. Immun. 12, 714 (1975)
Chedid, L., Audibert, F., Lefrancier, P., Choay, J., Lederer, E.: Modulation of the immune response by a synthetic adjuvant and analogs. Proc. Natl. Acad. Sci. USA 73, 2472 (1976)
Chen, C. H., Johnson, A. G., Kasai, N., Key, B. A., Levin, J., Nowotny, A.: Heterogeneity and biological activity of endotoxic glycolipid from Salmonella minnesota R595. J. Infect. Dis. 128, S43 (1973)
Ellouz, F., Adam, A., Ciorbaru, R., Lederer, E.: Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59, 1317 (1974)
Frankel, M., Ladkeny, D., Gilon, C., Wolman, Y.: The preparation of alkyloxycarbonyl amino acids and their N-hydroxysuccinimide esters. Tetrahedron Letters 39, 4765 (1966)
Galanos, C., Lüderitz, O., Westphal, O.: A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 9, 245 (1969)
Granger, D. L., Yamamoto, K., Ribi, E.: Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J. Immunol. 116, 482 (1976)
Gratia, A., Linz, R.: Le phénomène de Shwartzman dans la Sarcome du cobaye. C.R. Soc. Biol. (Paris) 108, 427 (1931)
Hakomori, S.-I.: Structures and organization of cell surface glycolipids dependency on cell growth and malignant transformation. Biochem. Biophys. Acta 417, 55 (1975)
Haskins, W. T., Landy, M., Milner, K. C., Ribi, E.: Biological properties of parent endotoxins and lipoid fractions, with a kinetic study of acid-hydrolyzed endotoxin. J. Exp. Med. 114, 665 (1961)
Hausman, M. S., Snyderman, R., Mergenhagen, S. E.: Humoral mediators of chemotaxis of mononuclear leukocytes. J. Infect. Dis. 125, 595 (1972)
Hibbs, J. B., Jr., Taintor, R. R., Chapman, H. A., Jr., Weinberg, J. B.: Macrophage tumor killing: influence of the local environment. Science 197, 279 (1977)
Hoffman, M. K., Green, S., Old, L. J., Oettgen, H. F.: Serum containing endotoxin-induced tumour necrosis factor substitutes for helper T cells. Nature 263, 416 (1976)
Hortobagyi, G. N., Gutterman, J. U., Snyder, R. D., Richman, S. P., Hersh, E. M.: Pseudomonas vaccine: A phase I evaluation for cancer research. Cancer Immunol. Immunother. 4, 201 (1978)
Johnson, A. G., Nowotny, A.: Relationship of structure to function in bacterial 0 antigens. III. Biological properties of endotoxins. J. Bacteriol. 87, 809 (1964)
Katsoyannis, P. G., Schwartz, G. P.: The synthesis of peptides by homogeneous solution procedures. Methods Enzymol. 47, 507 (1977)
Kelly, M. T., Granger, D. L., Ribi, E., Milner, K. C., Strain, S. M., Stoenner, H. G.: Tumor regression with Q fever rickettsia and a mycobacterial glycolipid. Cancer Immunol. Immunother. 1, 187 (1976)
Kelly, M. T., McLaughlin, C. A., Ribi, E. E.: Eradication of microscopic lymph node metastases of the guinea pig line 10 tumor after intralesional injection of endotoxin plus mycobacterial components. Cancer Immunol. Immunother. 4, 29 (1978)
Kotani, S., Watanabe, Y., Kinoshita, F., Shimono, T., Morisaki, T., Shiba, T., Kusumoto, S., Tarumi, Y., Ikenaka, K.: Immunoadjuvant activities of synthetic N-acetylmuramylpeptides or amino acids. Biken J. 18, 105 (1975)
Kusumoto, S., Ikenaka, K., Shiba, T.: Synthesis of N-acetylmuramyl-l-[U-14C] alanyl-d-isoglutamine. Tetrahedron Letters 46, 4055 (1977)
Lefrancier, P., Choay, J., Derrien, M., Lederman, I.: Synthesis of N-acetyl-muramyl-l-alanyl-d-isoglutamine, an adjuvant of the immune response, and some of N-acetyl-muramyl-peptide analogs. Int. J. Pept. Protein Res. 9, 249 (1977)
Lüderitz, O., Galanos, C., Lehmann, V., Mayer, H., Rietschel, E. T., Weekesser, J.: Chemical structure and biological activities of lipid A's from various bacterial families. Naturwissenschaften 65, 578 (1978)
McIntire, F. C., Hargie, M. P., Schenck, J. R., Finley, R. A., Siever, H. W., Rietschel, E. T., Rosenstreich, D. L.: Biologic properties of nontoxic derivatives of lipopolysaccharide from Escherichia coli K235. J. Immunol. 117, 674 (1976)
McLaughlin, C. A., Bickel, W. D., Kyle, J. S., Ribi, E.: Synergistic tumor-regressive activity observed following treatment of line-10 hepatocellular carcinomas with deproteinized BCG cell walls and mutant Salmonella typhimurium glycolipid. Cancer Immunol. Immunother. 5, 45 (1978a)
McLaughlin, C. A., Ribi, E. E., Goren, M. B., Toubiana, R.: Tumor regression induced by refined microbial components in an oil-inwater emulsion is mediated through their binding to oil droplets. Cancer Immunol. Immunother. 4, 109 (1978b)
McLaughlin, C. A., Strain, S. M., Bickel, W. D., Goren, M. B., Azuma, I., Milner, K., Cantrell, J. L., Ribi, E.: Regression of line-10 hepatocellular carcinomas following treatment with water-soluble, microbial extracts combined with trehalose or arabinose mycolates. Cancer Immunol. Immunother. 4, 61 (1978c)
McLaughlin, C. A., Hargrave, S. L., Bickel, W. D., Ribi, E.: Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line 10 tumors in guinea pigs. Cancer Immunol. Immunother. (in press, 1979)
Merser, C., Sinaÿ, P., Adam, A.: Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 66, 1316 (1975)
Meyer, T. J., Ribi, E., Azuma, I.: Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin. Cell. Immunol. 16, 11 (1975)
Milner, K. C., Finkelstein, R. A.: Bioassay of endotoxin: Correlation between pyrogenicity for rabbits and lethality for chick embryos. J. Infect. Dis. 116, 529 (1966)
Milner, K. C., Rudbach, J. A., Ribi, E.: General characteristics. In: Microbial toxins, bacterial endotoxins, Vol. 4, p. 1. New York: Academic Press 1971
Nauts, H. C., Swift, W. E., Coley, B. L.: Treatment of malignant tumors by bacterial toxins as developed by late William B. Coley, M.D., reviewed in light of modern research. Cancer Res. 6, 205 (1946)
Ng, A. K., Chang, C. M., Nowotny, A.: Comparison of the chemical structure and biological activities of the glycolipids of Salmonella minnesota R595 and Salmonella typhimurium SL1102. Infect. Immun. 10, 938 (1974)
Ng, A. K., Chen, C. H., Chang, C. M., Nowotny, A.: Relationship of structure to function in bacterial endotoxins: Serologically cross-reactive components and their effect on protection of mice against some gram-negative infections. J. Gen. Microbiol. 94, 107 (1976)
Nigam, V. N.: Effect of core lipopolysaccharides from Salmonella minnesota R mutants on the survival times of mice bearing Ehrlich tumor. Cancer Res. 35, 628 (1975)
Nowotny, A.: Endotoxoid preparations. Nature 197, 721 (1963a)
Nowotny, A.: Relation of structure to function in bacterial antigens. II. Fractionation of lipids present in Boivin-type endotoxin of Serratia marcescens. J. Bacteriol. 85, 427 (1963b)
Nowotny, A.: Relationship of structure and biological activity of bacterial endotoxins. Naturwissenschaften 58, 397 (1971)
Osborn, M. J.: Studies on the gram-negative cell wall. I. Evidence for the role of 2-keto-3-deoxyoctonate in the lipopolysaccharide of Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 50, 499 (1963)
Rapp, H. J.: A guinea pig model for tumor immunology: A summary. Isr. J. Med. Sci. 9, 366 (1973)
Ribi, E., Haskins, W. T., Landy, M., Milner, K. C.: Preparation and host-reactive properties of endotoxin with low content of nitrogen and lipid. J. Exp. Med. 114, 647 (1961)
Ribi, E., Anacker, R. L., Brehmer, W., Goode, G., Larson, C. L., List, R. H., Milner, K. C., Wicht, W. C.: Factors influencing protection against experimental tuberculosis in mice by heat-stable cell wall vaccines. J. Bacteriol. 92, 869 (1966)
Ribi, E., Parker, R., Milner, K. C.: Microparticulate gel chromatography accelerated by centrifugal force and pressure. Methods Biochem. Anal. 22, 355 (1974)
Ribi, E. E., Granger, D. L., Milner, K. C., Strain, S. M.: Brief communication: Tumor regression caused by endotoxins and mycobacterial fractions. J. Natl. Cancer Inst. 55, 1253 (1975a)
Ribi, E., Meyer, T. J., Azuma, I., Parker, R., Brehmer, W.: Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent Mycobacterium tuberculosis. Cell. Immunol. 16, 1 (1975b)
Ribi, E., Milner, K. C., Granger, D. L., Kelly, M. T., Yamamoto, K., Brehmer, W., Parker, R., Smith, R. F., Strain, S. M.: Immunotherapy with nonviable microbial components. Ann. N.Y. Acad. Sci. 277, 228 (1976a)
Ribi, E., Milner, K., Kelly, M. T., Granger, D., Yamamoto, K., McLaughlin, C. A., Brehmer, W., Strain, S. M., Smith, R. F., Parker, R.: Structural requirements of microbial agents for immunotherapy of the guinea pig line-10 tumor. In: BCG in cancer immunotherapy, p. 51. New York: Grune and Stratton 1976b
Ribi, E., Takayama, K., Milner, K., Gray, G. R., Goren, M., Parker, R., McLaughlin, C., Kelly, M.: Regression of tumors by an endotoxin combined with trehalose mycolates of differing structure. Cancer Immunol. Immunother. 1, 265 (1976c)
Ribi, E., McLaughlin, C. A., Cantrell, J. L., Brehmer, W., Azuma, I., Yamamura, Y., Strain, S. M., Hwang, K. M., Toubiana, R.: Immunotherapy for tumors with microbial constituents or their synthetic analogues. A review. In: Immunotherapy of human cancer, p. 131. New York: Raven Press 1978
Richman, S. P., Gutterman, J. U., Hersh, E. M., Ribi, E. E.: Phase III study of intratumor immunotherapy with BCG cell wall skeleton plus P3: Brief communication. Cancer Immunol. Immunother. 5, 41 (1978)
Rietschel, E. T., Galanos, C., Tanaka, A., Ruschmann, E., Lüderitz, O., Westphal, O.: Biological activities of chemically modified endotoxins. Eur. J. Biochem. 22, 218 (1971)
Risse, H. J., Dröge, W., Ruschmann, E., Lüderitz, O., Westphal, O., Schlosshardt, J.: Serologische und biochemische Analyse des Heptosekerns von Lipopolysacchariden aus Salmonella minnesota und Salmonella ruirumutantun. Eur. J. Biochem. 1, 216 (1967)
Schenck, J. R., Hargie, M. P., Brown, M. S., Ebert, D. S., Yoo, A. L., McIntire, F. C.: The enhancement of antibody formation by Escherichia coli lipopolysaccharide and detoxified derivatives. J. Immunol. 102, 1411 (1969)
Shwartzman, G., Michailovsky, N.: Phenomenon of local skin reactivity to bacterial filtrates in the treatment of mouse Sarcoma 180. Proc. Soc. Exp. Biol. Med. 29, 737 (1932)
Suter, E., Kirsanow, E. M.: Hyperreactivity to endotoxin in mice infected with mycobacteria. Induction and elicitation of the reactions. Immunology 4, 354 (1964)
Toubiana, R., Ribi, E., McLaughlin, C., Strain, S. M.: The effect of synthetic and naturally occurring trehalose fatty acid esters in tumor regression. Cancer Immunol. Immunother. 2, 189 (1977)
Vosika, G. J., Schmidtke, J. R., Goldman, A., Ribi, E., Parker, R., Gray, G. R.: Immunotherapy of melanoma with cell wall skeleton and trehalose dimycolate (P3). Cancer (in press, 1979)
Westphal, O., Lüderitz, O.: Chemische Erforschung von Lipopolysacchariden gramnegativer Bakterien. Angew. Chem. 66, 407 (1954)
Westphal, O., Lüderitz, O., Bister, F.: Über die Extraktion von Bakterien mit Phenol/Wasser. Z. Naturforsch. [B] 7, 148 (1952)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ribi, E., Parker, R., Strain, S.M. et al. Peptides as requirement for immunotherapy of the guinea-pig line-10 tumor with endotoxins. Cancer Immunol Immunother 7, 43–58 (1979). https://doi.org/10.1007/BF00205409
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00205409